Browse > Article

Antiviral and Tumoricidal Activities of Alginate-Stimulated Macrophages are Mediated by Different Mechanisms  

Son, Eun-Wha (Korea Institute of Science and Technology Information)
Rhee, Dong-Kwon (Korea and College of Pharmacy, Sungkyunkwan University)
Pyo, Suhk-Neung (Korea and College of Pharmacy, Sungkyunkwan University)
Publication Information
Archives of Pharmacal Research / v.26, no.11, 2003 , pp. 960-966 More about this Journal
Abstract
Macrophages play an important role in host defenses by killing tumors and virus infections and producing secretory products. High mannuronic acid (HMA) containing alginate was examined to determine the mechanisms by which HMA-activated macrophages resist infection with HSV-1 and inhibit the growth of tumor cells. The ability of macro phages to resist infection with HSV-1 or to inhibit the growth of tumor cells was assessed following treatment with HMA alginate in the presence of either antibodies to various cytokines or inhibitors/scavengers of toxic macrophage products. Only antibodies to IFN-$\alpha$/$\beta$ were able to abrogate the protective effects of HMA alginate in macrophages infected with HSV-1, suggesting that the antiviral activity induced by this immunomodulator was mediated by the production of IFN-$\beta$. In contrast, anti-TNF-$\alpha$, anti-IFN and inhibitors of nitric oxide and reactive oxygen species were all able to partially abrogate HMA-induced cytostatic activity, suggesting that multiple mechanisms are involved in macrophage cytostasis. These results indicate that the HMA-induced intrinsic antiviral and extrinsic cytotoxic activites are mediated by different mechanisms.
Keywords
Alginate; Macrophage; Antiviral; Tumoricidal;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Davidson, I. W., Sutherland, Z. W., and Lawson, C. J., Purification and properties of an alginate lyase from a marine bacterium. Biochem. J., 159, 707-713 (1976)   DOI   PUBMED
2 Ding, A. H., Nathan, C. F., and Stuehr, D. J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol., 141, 2407-2412 (1988)   PUBMED
3 El Messaoudi, K., Verheyden, A. M., Thiry, L., Fourez, S., Tasiaux, N., Bollen, A., and Moguilevsky, N., Human recombinant myeloperoxidase antiviral activity on cytomegalovirus. J. Med. Virol., 66, 218-223 (2002)   DOI   ScienceOn
4 Fan, M. Y., Lum, Z. P., Fu, X. W., Levesque, L., and Tai, I. T., Reversal of diabetes in BB rats in transplantation of encapsulated pancreatic islets. Diabetes, 39, 519-522 (1990)   DOI   ScienceOn
5 Gao, J. J., Filla, M. B., Fultz, M. J., Vogel, S. N., Russell, S. W., and Murphy, W. J., Autocrine/paracrine IFN-$\alpha$/$\beta$ mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J. Immunol., 161, 4803-4810 (1998)   PUBMED
6 Hibbs, J. B. Jr., Taintor, R. R., and Vavrin, Z., Macrophage cytotoxicity: role for L-arginine deaminase and imino nitrogen oxidation to nitrite. Science, 235, 473-476 (1987a)   DOI   PUBMED
7 Mavier, P. and Edgington, T. S., Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism. J. Immunol., 132, 1980-1986 (1984)   PUBMED
8 Rager-Zisman, B., Kunkel, M., Tanaka, Y., and Bloom, B. R., Role of macrophage oxidative metabolism in resistance to vesicular stomatitis virus infection. Infect. Immun., 36, 1229-1237 (1982)   PUBMED
9 Remels, L., Fransen, L., Huygen, K., and De Baetselier, P., Poly I:C activated macrophages are tumoricidal for TNF-alpharesistant 3LL tumor cells. J. Immunol., 144, 4477-4486 (1990)   PUBMED
10 Son, E. H., Moon, E. Y., Rhee, D. K., and Pyo, S., Stimulation of various functions in murine peritoneal macrophages by high mannuronic acid-containing alginate (HMA) exposure in vivo. Int. Immunopharmacol., 1, 147-154 (2001)   DOI   ScienceOn
11 Takahashi, K., Watanuki, Y., Yamazaki, M., and Abe, S., Local induction of a cytotoxic factor in a murine tumor by systemic administration of an antitumor polysaccharide, MGA. Br. J. Cancer., 57, 170-173 (1988)   DOI   ScienceOn
12 Tsujimoto, M., Feinman, R., and Vilcek, J., Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines. J. Immunol., 137, 2272-2276 (1986)   PUBMED
13 Wong, G. H. and Goeddel, D. V., Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature, 323, 819-822 (1986)   DOI   ScienceOn
14 Dinarello, C. A., Interleukin-1. Rev. Infect. Dis., 6, 51-95 (1984)   DOI   PUBMED
15 Arden, L., Lansdorp, P., and De Groot, E., A growth factor for B cell hybridomas produced by human monocytes. Lymphokines, 10, 175-185 (1985)
16 Choriki, M., Freudenberg, M., Calanos, C., Poindron, P., and Bartholeyns, J., Antitumoral effects of lipopolysaccharide, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res., 9, 1185-1190 (1989)   PUBMED
17 Morahan, P. S., Interactions of herpesviruses with mononuclear phagocytes. In Rouse, B. T., Lopez, C., Immunobiology of herpes simplex virus infection. CRC Press, Boca Raton, pp. 71-89 (1984)
18 Otterle, M., Ostgaard, K., Skjak-Braek, G., Smidsrod, O., and Soon-Shiong, P., Induction of cytokine production from human monocytes stimulated by alginate. J. Immunother., 10, 286-291 (1991)   DOI   PUBMED
19 Seljelid, R., Figenschau, Y., Bogwald, J., Rasmussen, L. T., and Austgulen, R., Evidence that tumor necrosis induced by aminated beta 1-3D polyglucose is mediated by a concerted action of local and systemic cytokines. Scand. J. Immunol., 30, 687-694 (1989)   DOI   ScienceOn
20 Stuehr, D. J. and Marletta, M. A., Synthesis of nitrite and nitrate in macrophage cell lines. Cancer Res., 47, 5590-5594 (1987)   PUBMED
21 Djeraba, A., Bernardet, N., Dambrine, G., and Quere P., Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition. Virology, 277, 58-65 (2000)   DOI   PUBMED   ScienceOn
22 Miner, K. M. and Nicolson, G. L., Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis. Cancer Res., 43, 2063-2067 (1983)   PUBMED
23 Proietti, E., Gessani, S., Belardelli, F., and Gresser, I., Mouse peritoneal cells confer an antiviral state on mouse cell monolayers: role of interferon. J. Virol., 57, 456-463 (1986)   PUBMED
24 Verstovsek, S., Maccubbin, D., and Mihich, E., Tumoricidal activation of murine resident peritoneal macrophage by interleukin 2 and tumor necrosis factor. Cancer Res., 52, 3880-3885 (1992)   PUBMED
25 Cohn, Z. A., Activation of mononuclear phagocytes: fact, fancy, and future. J. Immunol., 121, 813-816 (1978)   PUBMED
26 Saiki, I. and Fidler, I. J., Synergistic activation of recombinant mouse interferon-and muramyl dipeptide of tumoricidal properties in mouse peritoneal macrophages. J. Immunol., 135, 684-688 (1984)
27 Decker, T., Lohmann-Matthes, M. L., and Gifford, G. E., Cellassociated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol., 138, 957-962 (1987)   PUBMED
28 Miner, K. M., Klostergaard, J., Granger, G. A., and Nicolson, G. L., Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma. J. Natl. Cancer Inst., 70, 717-724 (1983)   PUBMED
29 Higuchi, M., Higashi, N., Taki, H., and Osawa, T., Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. J. Immunol., 144, 1425-1431 (1990)   PUBMED
30 Arenzana-Seisdedos, F. and Virelizier, J., Interferons as macrophage activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes. Eur. J. Immunol., 13, 437-444 (1983)   DOI   ScienceOn
31 Dullens, H. F. J., De Weger, R. A., Van Der Maas, M., Den Besten, P. J., Vandebriel, R. J., and Den Otter, W., Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection. Cancer Immunol. Immunother., 30, 28-33 (1989)   DOI   ScienceOn
32 Keller, R., Keist, R., and Frei, K., Lymphokines and bacteria that induce tumoricidal activity, trigger a different secretory response in macrophages. Eur. J. Immunol., 20, 695-698 (1990)   DOI   ScienceOn
33 Pyo, S., Gangemi, J. D., Ghaffar, A., and Mayer, E. P., Poly I:Cinduced anti-herpes simplex virus type 1 activity in inflammatory macrophages is mediated by induction of interferonbeta. J. Leukoc. Biol., 50, 479-487 (1991)   DOI   PUBMED
34 Soon-Shiong, P., Henitz, R. E., Merideth, N., Yao, Q. X., and Zheng, T., Insulin independence in a type I diabetic patient after encapsulated islet transplantation. Lancet, 343, 950-951 (1994)   DOI   ScienceOn
35 Hibbs, J. B. Jr., Vavrin, Z., and Taintor, R. R., L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol., 138, 550-565 (1987b)   PUBMED
36 Tze, W. J. and Tai, J. Biocompatibility and immunological studies of microencapsulation with cross-linked alginate capsules. Transplantation, 33, 563-564 (1982)   DOI   ScienceOn
37 Gautam, S. and Deodhar, S., Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study. J. Biol. Res. Modif., 8, 560-569 (1989)
38 Iizima-Mizui, N,, Fujihara, M., Himeno, J., Komiyama, K., Umezawa, I., and Namuno T. Antitumor activity of polysacchride fraction from the brown seaweed sargassum kjellmanianum. Kitasato, Arch. Exp. Med., 58, 59-71 (1985)
39 Morahan, P. S., Connor, J. R., and Leary, K. R., Viruses, and the versatile macrophage. Br. Med. Bull., 41, 15-21 (1985)   DOI   PUBMED
40 Sharon, N., Shoham, J., and Passwell, J. H., Enhancement of human monocyte cytotoxicity by both interferon-gamma and -beta and comparison to other stimuli. Int. J. Immunopharmacol., 11, 743-749 (1989)   DOI   ScienceOn
41 Sit, M. F., Tenney, D. J., Rothstein, J. L., and Morahan, P. S., Effect of macrophage activation on resistance of mouse peritoneal macrophages to infection with herpes simplex virus types 1 and 2. J. Gen. Virol., 69, 1999-2010 (1988)   DOI   ScienceOn
42 Darquy, S. and Sun, A. M., Microencapsulation of parathyroid cells as a bioartificial parathyroid in vitro studies. ASAIO J., 33, 356-358 (1987)
43 Paulnock, D. M. and Lambert, L. E., Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. J. Immunol., 144, 765-773 (1988)
44 Greene, J. J., Double-stranded RNA and its analogs: The prospects and the promise of the first nucleic acid therapeutic agent: In Strangefellow, D. A., Clinical Applications of Interferon and IFN Inducers. Marcel Dekker, New York, pp. 245-268 (1986)
45 Pyo, S., The mechanism of poly I: C-induced antiviral activity in peritoneal macrophage. Arch. Pharm. Res., 17, 93-99 (1994)   DOI   PUBMED   ScienceOn